A Case of Aspergillosis of the Central Nervous System in an Immunocompetent Patient

면역력이 정상인 환자에서 발생한 중추신경계의 아스페르길루스증 1예

  • Joe, Byung-Hyun (Department of Internal Medicine, Kyung Hee University School of Medicine) ;
  • Hwang, Eun-Jung (Department of Internal Medicine, Kyung Hee University School of Medicine) ;
  • Park, So-Youn (Department of Internal Medicine, Kyung Hee University School of Medicine) ;
  • Son, Jun-Sung (Department of Internal Medicine, Kyung Hee University School of Medicine) ;
  • Lee, Mi-Suk (Department of Internal Medicine, Kyung Hee University School of Medicine)
  • 조병현 (경희대학교 의학전문대학원 내과학교실) ;
  • 황은정 (경희대학교 의학전문대학원 내과학교실) ;
  • 박소연 (경희대학교 의학전문대학원 내과학교실) ;
  • 손준성 (경희대학교 의학전문대학원 내과학교실) ;
  • 이미숙 (경희대학교 의학전문대학원 내과학교실)
  • Published : 2011.05.01

Abstract

Invasive aspergillosis usually does not occur in immunocompetent patients. Recently, however, the incidence of invasive aspergillosishas been increasing in immunologically competent patients. It is difficult to diagnose neuroaspergillosis because of its variedradiological findings and clinical manifestations. We report a case of aspergillosis of the central nervous system, presenting as amass-like lesion, in an immunocompetent patient. The patient was diagnosed after a surgical biopsy and treated with antifungalagents. The clinical outcome was good.

침습성 아스페르길루스증은 면역학적으로 저하되어 있는 경우에 흔한 것으로 알려져 있으나 최근 면역학적으로 정상인 자에서 발생하는 빈도가 과거에 비해 증가 추세이며 중추신경계에서 발생하는 경우 그 임상양상이나 방사선학적 소견이 다양하기 때문에 초기 진단이 쉽지 않다. 본 저자들은 면역학적으로 정상인 환자에서 뇌종양 양상으로 중추신경계에 발생한 침습성 아스페르길루스증을 경험하였기에 이를 보고하는 바이다.

Keywords

References

  1. Chatzimichalis A, Massard G, Kessler R, et al. Bronchopulmonary aspergilloma: a reappraisal. Ann Thorac Surg 1998;65:927-929. https://doi.org/10.1016/S0003-4975(98)00060-5
  2. Denning DW. Invasive aspergillosis. Clin Infect Dis 1998;26: 781-803. https://doi.org/10.1086/513943
  3. Bodey GP, Vartivarian S. Aspergillosis. Eur J Clin Microbiol Infect Dis 1989;8:413-437. https://doi.org/10.1007/BF01964057
  4. Nadkarni T, Goel A. Aspergilloma of the brain: an overview. J Postgrad Med 2005;51(Suppl 1):S37-S41.
  5. Bennett JE. Aspergillosis. In: Kasper DL, Fauci AS, Braunwald E, Hauser SL, Longo DL, Jameson L, Isselbacher KJ, eds. Harrison`s textbook of internal medicine. 16th ed. New York: McGraw-Hill, 2005:1188-1190.
  6. 김양수, 김성민, 백경란 등. 침습성 Aspergillosis의 임상적 고찰. 대한내과학회지 1990;38:526-537.
  7. Phuttharak W, Hesselink JR, Wixom C. MR features of cerebral aspergillosis in an immunocompetent patient: correlation with histology and elemental analysis. Am J Neuroradiol 2005; 26:835-838.
  8. Clancy CJ, Nguyen MH. Acute community-acquired pneumonia due to aspergillus in presumably immunocompetent hosts: clues for recognition of a rare but fatal disease. Chest 1998;114: 629-634. https://doi.org/10.1378/chest.114.2.629
  9. Kim DG, Hong SC, Kim HJ, et al. Cerebral aspergillosis in immunologically competent patients. Surg Neurol 1993;40: 326-331. https://doi.org/10.1016/0090-3019(93)90145-Q
  10. Sood S, Sharma R, Gupta S, Pathak D, Rishi S. Neuroaspergillosis in an immunocompetent patient. Indian J Med Microbiol 2007; 25:67-69. https://doi.org/10.4103/0255-0857.31068
  11. Denning DW. Diagnosis and management of invasive aspergillosis. Curr Clin Top Infect Dis 1996;16:277-299.
  12. 송경호, 이신원, 장희창 등. 침습성 아스페르길루스증 진단을 위한 갈락토만난 항원 검사의 유용성 평가. 감염과화학요법 2009;41:82-89.
  13. Yamada K, Shrier DA, Rubio A, et al. Imaging findings in intracranial aspergillosis. Acad Radiol 2002;9:163-171. https://doi.org/10.1016/S1076-6332(03)80166-6
  14. Walsh TJ, Anaissie EJ, Denning DW, et al. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2008;46:327-360. https://doi.org/10.1086/525258
  15. Herbrecht R, Denning DW, Patterson TF, et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002;347:408-415. https://doi.org/10.1056/NEJMoa020191
  16. Arikan S, Sancak B, Alp S, Hascelik G, McNicholas P. Comparative in vitro activities of posaconazole, voriconazole, itraconazole, and amphotericin B against Aspergillus and Rhizopus, and synergy testing for Rhizopus. Med Mycol 2008;46:567-573. https://doi.org/10.1080/13693780801975576